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ABSTRACT
* 
Objectives: This study aimed to investigate the 
prevalence, disclosure and adverse effects of 
complementary and alternative medicine (CAM) use 
in hospitalised patients, and to explore the 
associations between patients’ perceived side-
effects and relevant factors.  
Methods: Patients who were admitted to a district 
general hospital and met the eligibility criteria were 
interviewed using a semi-structured questionnaire. 
Their medications and pertinent details were verified 
from the medical notes. All quantitative and 
qualitative data were collated and analysed. A chi-
squared test was performed to test the associations 
of the perceived CAM side-effects with the 
significance level determined at α=0.05.  
Results: A total of 240 in-patients completed the 
study. They were mostly white British (98.8%). The 
prevalence of CAM use within two years was 74.6% 
and one month 37.9%. Only 19 of 91 patients 
(20.9%) using CAM within one month disclosed 
their current CAM applications. Nearly half of 
patients (45.8%) who used CAM within two years 
experienced various CAM side-effects that tended 
to resolve after discontinuation. Slightly more than 
half (57.6%) perceived CAM side-effects and their 
perceptions were significantly associated with 
gender (P=0.048) and consideration for future CAM 
use (P=0.033). Potential interactions between 
herbal remedies/dietary supplements and 
prescribed drugs, such as garlic with lisinopril or 
aspirin, were assessed in 82 patients (45.8%).  
Conclusion: Most in-patients used CAM and 
experienced some adverse effects. The disclosure 
of CAM use and its adverse outcomes should be 
encouraged by healthcare professionals. 
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ADVERTENCIAS Y EFECTOS ADVERSOS 
DE LAS MEDICINAS ALTERNATIVAS Y 
COMPLEMENTARIAS USADAS POR 
PACIENTES HOSPITALIZADOS EN EL 
NORESTE DE INGLATERRA 
 
RESUMEN 
Objetivos: Este estudio trató de investigar la 
prevalencia, advertencia y efectos adversos de las 
medicinas alternativas y complementarias (CAM) 
usadas por pacientes hospitalizados, y explorar las 
asociaciones entre los efectos adversos percibidos 
por los pacientes y factores relevantes. 
Métodos: Se entrevistó usando un cuestionario 
semi-estructurado a los pacientes que fueron 
admitidos en un hospital general distrital y que 
cumplían los criterios de elegibilidad. Se 
comprobaron los medicamentos y otros detalles 
pertinentes en la historia clínica de los pacientes. Se 
recogieron y analizaron todos los datos 
cuantitativos y cualitativos. Para comprobar las 
asociaciones de los efectos adversos percibidos de 
las CAM se realizó un test chi-cuadrado con un 
nivel de significación de α=0,05. 
Resultados: Un total de 240 pacientes 
hospitalizados completó el estudio. Eran 
mayoritariamente británicos (98,8%). La 
prevalencia de uso de CAM en dos años fue del 
74,6% y en un mes del 37,9%.  Sólo 19 de los 91 
pacientes (20,9%) que usaron CAM en el último 
mes reveló su uso actual. Casi la mitad de los 
pacientes (45,8%) que usaron CAM en los dos 
últimos años sufrió algunos efectos adversos de las 
CAM que tendieron a resolverse después de 
abandonarlas. Ligeramente más de la mitad 
(57,6%) percibieron efectos adversos de las CAM y 
su percepción estaba significativamente asociada 
con el género (P=0,048) y con la consideración 
sobre el futuro uso de CAM (P=0,033). En 82 
pacientes (45,8%) se encontró interacciones 
potenciales entre plantas medicinales/suplementos 
dietéticos y medicamentos prescritos, tales como 
ajo con lisinoprilo o aspirina. 
Concusión: La mayoría de los pacientes 
hospitalizados usó CAM y percibió algunos efectos 
adversos. La advertencia del uso de CAM y sus 
efectos adversos debería ser incentivada por los 
profesionales de la salud.  
 
Palabras clave: Terapias Complementarias. 
Revelación. Pacientes Internos. Reino Unido. 
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INTRODUCTION 
The public and patients have increasingly used 
complementary and alternative medicine (CAM) 
together with conventional medicine to treat or 
prevent some medical conditions. According to the 
World Health Organization (WHO), CAM that is 
interchangeably used with ‘traditional medicine’ 
refers to “a broad set of health care practices that 
are not part of that country's own tradition and are 
not integrated into the dominant health care 
system”.
1 CAM practices
2,3 exploited by patients can 
be generally grouped into natural products, mind-
body medicine, manipulative and body-based 
practices, and other practices, e.g. movement 
therapies, qigong, etc. Some studies
4,5 in the UK 
reported as high as 69% to 71% of patients use one 
or more forms of CAM at some point in life. 
However, healthcare professionals are not often 
aware of CAM used by patients.
6-8 Giveon et al.
7 
pointed out that nearly half of ‘natural product’ users 
(44.7%) never informed the physicians of their 
usage, and 29.7 percent of respondents did not 
think the use of alternative medicine or natural 
products should be reported to the physicians. 
Patients’ disclosure of CAM use and reasons for 
non-disclosure therefore need be fully investigated 
in order to ensure the patient safety.  
Potential adverse effects are a matter of concern 
among patients using CAM.
9,10 These effects may 
have an impact on patients’ pathology, 
complications of medical conditions or delay in 
medical diagnosis. Additionally, apprehensions are 
particularly reported with patients receiving multiple 
drug therapy and CAM usage. As for conventional 
drugs, herbal remedies and dietary supplements 
(HS) are pharmacologically active and possess 
some risks of side-effects and interactions with drug 
therapy.
11-13 This could lead to therapeutic failure by 
reducing systemic absorption or bioavailability of 
conventional medications, toxicity or an extension of 
hospital stay, which are all unwanted 
consequences. The adverse effects of CAM 
experienced by patients nevertheless remain 
unclear and merit further investigation. 
Many CAM studies
5,7,14-16 have been carried out in 
patients attending GP surgeries or hospital out-
patient units, but very few
8,17,18 were conducted in 
hospitalised patients. These few questionnaire 
surveys mainly focused on the use of CAM and 
reasons for use. This study was thus intended to 
investigate the prevalence, disclosure and adverse 
effects of CAM used by in-patients and to find out 
any associations between patients’ perceived CAM 
side-effects and relevant factors. It may enable 
pharmacists and healthcare professional to gain an 
insight into patients’ use of CAM, their disclosure 
and adverse effects that are crucial for patient care 
and medicines management. 
 
METHODS  
This cross-sectional study was carried out in 
hospitalised patients of a district general hospital in 
the North East of England from November 2008 to 
November 2009. The study was approved by the 
National Research Ethics Service Committee 
(NRES) in the UK and the University’s ethics 
committee. Other permissions granted included the 
Caldicott Guardians for personal data protection, 
NHS Research and Development and audit quality 
improvement of Northumbria NHS Healthcare Trust.  
In this study, the utilisation of ‘complementary and 
alternative medicine’ (CAM) refers to patients’ use 
of one or more types of therapies or medicines that 
are not usually prescribed by general practitioners 
or pharmacists, and may be bought from health 
shops. To facilitate the data analysis and 
interpretation, CAM was divided into two groups: 
herbal remedies and dietary supplements (HS, e.g. 
natural products, vitamins and mineral 
supplements) and other forms of CAM (non-HS, e.g. 
homeopathy, aromatherapy, massage and 
acupuncture). Adverse effects here included (1) 
suspected adverse CAM reactions (or so-called 
‘actual CAM side-effects’) reported by in-patients, 
(2) perceived CAM side-effects and (3) potential 
interactions between herbal remedies/dietary 
supplements (HS) and prescribed medicines. For 
other forms of CAM (non-HS), their interactions with 
mainstream medicines were not evaluated owing to 
the incomplete data obtained from hospitalised 
patients and medical notes; this made it difficult to 
assess the interactions.  
With respect to patients’ reports of actual CAM side-
effects, a simple causality assessment that 
confirmed the association of an adverse event with 
CAM were performed by using temporal sequence 
and documented evidence, e.g. reports of side-
effects or research papers. Naranjo’s Algorithm
20 
could not be utilised owing to the incomplete data, 
such as responses to ‘dechallenge’ or ‘rechallenge’ 
of CAM. All CAM side-effects were grouped up 
based on body systems specified in the British 
National Formulary (BNF)
21 and International 
Classification of Disease (ICD-10).
22 Potential 
interactions between patients’ HS and their 
allopathic drugs in this study are defined as drug-
CAM interactions that are likely to cause patients 
undesirable effects and can be explained by 
pharmacokinetics or pharmacodynamics. The 
adverse interactions were assessed by the 
researchers using standard information sources, i.e. 
Stockley’s Herbal Medicine Interaction
13 and 
Medical Pocket Reference: Drug-herb 
Interactions
23, and current evidence.
24-26 
Patients and eligibility criteria. The study 
participants were adult in-patients admitted to five 
specialty wards, i.e. Orthopaedics & Trauma, 
General Surgery, Elderly Medicine, General 
Medicine and Gynaecology. These wards were 
selected so as to provide a broader spectrum of 
patients than other studies that only emphasised 
specific patient groups. A few wards, such as 
Children and Oncology, were excluded, as it was 
not feasible to obtain patients’ data. Patients were 
included in the study if they were aged 16 or over 
and could provide written or oral consent. Exclusion 
criteria were: a mental health diagnosis, a diagnosis 
of cancer, a terminal illness, an inability to give 
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with the researchers in English. Medical and nursing 
staff on the wards could also exclude patients from 
the study if they felt it was inappropriate in terms of 
health and safety, as suggested by the ethics 
committee. In addition to a consent form, a 
participant information sheet was also provided for 
patients in order to clarify the purpose of the study, 
definition and examples of CAM, study activity and 
risk and benefit of participation, including 
confidentiality and voluntary withdrawal at any time.  
The sample size was estimated based on the 
prevalence of in-patients’ CAM use and the formula 
compiled by Eng
19, which is the required sample 
(N)=4(Zcrit)
2p(1-p)/d
2. Since different studies have 
different study designs and durations of CAM use, 
i.e. within 1-2 years or at some point in time, the 
prevalence rates considerably varied with the 
studies. The prevalence of 68.0% found in 
hospitalised patients who ever used CAM8 was 
chosen on account of its reliable findings. With a 
95% confidence interval and its expected width of 
10% - 20%, the sample size of 84 - 334 was 
therefore determined. When taking the incomplete 
data and patients’ responses into consideration, at 
least 200 patients were required to detect a 
prevalence rate in the study.  
Study instrument. A semi-structured questionnaire 
with closed and open-ended questions was 
specially developed based on the literature 
evidence. In the questionnaire, the single term 
‘alternative medicine’ with a simple definition was 
used to better communicate with patients. This 
questionnaire contained three sections. Section 1 
embraced patient’s characteristics, whereas Section 
2 consisted of the use of CAM and CAM adverse 
effects. Section 3 contained data extracted from 
patients’ medical notes, i.e. medical conditions, 
conventional drug use, records of CAM use, 
adverse effects, length of hospital stay and 
outcomes on discharge. The questionnaire was 
checked for content validity by three experts on 
complementary therapies, clinical pharmacy and 
statistics. It was then piloted in 82 patients attending 
health shops, community pharmacy and hospital, 
and eventually reviewed by the ethics committee.  
Data collection. In-patients who met the eligibility 
criteria were given unique identification codes, such 
as R1, R59 or R240. They were initially informed of 
the consent form and details of the study, and then 
interviewed face-to-face by the researcher (NB) 
using the questionnaire for approximately 25-60 
minutes. After that, the data found in patients’ 
medical notes were verified and recorded in Section 
3 of the questionnaire. Regarding patient safety, the 
researchers (NB and WB) would discuss with 
relevant ward pharmacists any CAM adverse effects 
reported by patients and resolved the problems 
accordingly. 
Data analysis. All quantitative data from completed 
questionnaires were entered into PASW Statistics 
18 (SPSS-IBM Co., Chicago, IL) and analysed by 
using descriptive statistics and a Chi-squared test or 
Fisher’s exact test. A significance level (alpha) was 
set at 0.05. NVivo 8.0 (QSR International (UK) Ltd., 
Southport, UK) was employed to manage the 
qualitative data obtained from open-response 
questions. Some obscure data from patients’ 
answers were highlighted for further interpretation. 
A content analysis with coding schemes based on 
previous studies and the data was performed by the 
researcher (NB). For instance, the coding schemes 
of reasons for disclosure of CAM use included: 
“asked by healthcare professionals” (HCP, if 
asked by healthcare providers, etc.) “willing to 
answer” (WTA, willing to admit using CAM) 
“attitudes of healthcare professionals” (ATT, 
good attitudes of healthcare professionals 
towards CAM use) 
“approved to use CAM” (APR, approved by 
healthcare providers to use CAM).  
The codes for non-disclosure of CAM application 
embraced: 
“did not consider CAM as medicine” (DCON, 
did not regard CAM as conventional 
medicine) 
“did not use CAM recently” (DUSE, did not 
use now so did not inform) 
“was not asked specifically about CAM” 
(WASK, was not asked directly about CAM 
use)  
“might mention if using” (MMEN, might 
mention if using/taking).  
The overall codes and results of the content 
analysis were rechecked using a small set of the 
data and eventually confirmed by the research 
team.  
 
RESULTS  
At the outset, 300 in-patients were recruited into the 
study. Of these, 44 refused to participate, 9 declined 
to give consent for reviewing medical notes and 7 
withdrew from the study during interviews. Thus, a 
total of 240 patients could be interviewed and their 
medical notes were accessed. The characteristics 
of the patients are shown in Table 1. There were 
slightly more females than males (54.6% vs. 
45.4%). Nearly half of them were older patients 
aged 60 or over (53.3%) with the mean age of 59.3 
(SD=17.3 years). They were mostly white British 
(98.8%) and educated at the college or level 
(56.7%). Moreover, most patients stayed on three 
major specialty wards, i.e. Orthopaedics and 
Trauma (33.3%), General Surgery (30.0%) and 
General Medicine (29.2%), for the median period of 
8 days (interquartile range: 4 – 14 days). 
Use of CAM. As demonstrated in Table 1, 179 
patients used CAM within two years, but 91 still 
utilised it within the period of one month prior to the 
interviews. The prevalence of CAM use within two 
years and one month was therefore 74.6% and 
37.9%, respectively. The specific types of CAM 
used by the patients are summarised in Table 2. 
Top 5 HS included nutritional oil (e.g. cod liver oil, 
omega-3 and seven seas), vitamins and mineral 
supplements, glucosamine, valerian products and 
herbal teas, whereas Top 5 non-HS reported were 
massage, aromatherapy, acupuncture, reflexology 
and homeopathic remedies. When enquired about 
the future use of CAM, the majority of patients Bello N, Winit-Watjana W, Baqir W, Mcgarry K. Disclosure and adverse effects of complementary and alternative 
medicine used by hospitalized patients in the North East of England. Pharmacy Practice (Internet) 2012 Jul-
Sep;10(3):125-135. 
www.pharmacypractice.org (ISSN: 1886-3655)  128
(71.3%) would consider using it after discharge 
because of previous experience with CAM 
effectiveness and less side-effects, professional 
recommendations, indicated conditions and its 
availability and accessibility. Some reasons 
rendered by patients, with their identification codes 
in the brackets, are as follows: 
“...beneficial, harmless, natural, normal, and 
has less side-effects than my prescription 
medicines.” (R9) 
“…will use it if doctors or nurses recommend 
or prescribe it.” (R15) 
“...concerned about the safety of convention 
medicine and once experienced some side-
effects, so like to use alternative medicine.” 
(R88) 
Disclosure of CAM use. For 179 patients who 
used CAM within two years, 14% informed 
healthcare professionals of their use of CAM (Table 
1). However, 19 of 91 patients (20.9%) who still 
made use of CAM within one month disclosed their 
current CAM usage. Their disclosure was also 
verified through the medical notes. The reasons for 
disclosure or non-disclosure are presented in Table 
3. Patients revealed their CAM use because of their 
own willingness to answer, good attitudes towards 
healthcare professionals or the manner of inquiry. 
On the contrary, they did not notify their CAM 
applications, since they did not consider CAM as 
medicines, did not use CAM by the time of inquiry, 
were not specially asked about CAM or 
misunderstood the question. 
CAM side-effects. In Table 1, slightly more than 
half (57.6%) perceived CAM might have some side-
effects, but the rest had no opinion or were 
undecided. Patients’ perceptions of CAM side-
effects derived from personal experience, the 
comparison of CAM safety profiles with 
conventional medicine, discontentment with 
unqualified CAM practitioners and unrestricted 
regulations. Views on CAM adverse effects 
included: 
“Lack of knowledge of alternative medicine 
itself. It might cause some unwanted effects.” 
(R18) 
“CAM information is not available like 
medications and no medical staff involved.” 
(R35) 
“It depends on individual sensitivity, personal 
experience and types.” (R107) 
In regard to actual experience with CAM side-
effects, 82 patients (45.8%) with 133 adverse 
events were reported; these included 53 females 
and 29 males. Their problems tended to resolve or 
subside on discontinuation (Table 1). All side-effects 
associated with CAM were regarded as ‘possible’ 
according to the simple causality assessment, as all 
patients had received CAM before the adverse 
effects occurred and there was some documented 
evidence to support the results. Table 4 
summarises actual CAM side-effected notified by 
the patients as classified by body systems. Most 
patients encountered gastrointestinal effects, e.g. 
constipation, darkened stool and diarrhoea, followed 
by problems in the central nervous system and 
musculoskeletal system. Examples of attributed 
CAM with its side-effects are as follows: 
Garlic - “…vomiting and mentioned to the 
doctor who said it might not agree with body, 
and the reaction subsided when stopped it.” 
(R61) 
Table 1.  Patients’ characteristics and use of complementary and alternative medicine (CAM) (n=240) 
Variable Attribute  Number of 
patients (%) 
Characteristics    
Gender 
 
Male  
Female 
109 (45.4) 
131 (54.6) 
Age group (years) 
 
 
 
16 – 39  
40 – 59 
> 60 
32 (13.3) 
80 (33.3) 
128 (53.3) 
Education 
 
 
None and Primary 
College: A-levels or equivalent  
Higher degrees 
68 (28.3) 
136 (56.7) 
36 (15.0) 
Ethnic background  White  
Asian 
237 (98.8) 
3 (1.2) 
Specialty ward
 
 
 
 
Orthopaedics & Trauma 
General Surgery 
General Medicine 
Elderly Medicine 
Gynaecology 
80 (33.3) 
72 (30.0) 
70 (29.2) 
10 (4.2) 
8 (3.3) 
Length of hospital stay
  Median (interquartile range)  8 (4 – 14) 
Use of CAM     
Use within two years  Yes  179 (74.6) 
Use within one month  Yes  91 (37.9) 
Consideration for future use  Yes  171 (71.3) 
Disclosure of CAM use  
  Those use within two years (n=179) 
  Those use within one month (n=91) 
 
Yes  
Yes 
 
25 (14.0) 
19 (20.9) 
Perceived CAM side-effects (n=236)  Yes  136 (57.6) 
Actual CAM side-effects (n=179)  Yes  82 (45.8) 
Potential HS interactions (n=179)  Yes  82 (45.8) Bello N, Winit-Watjana W, Baqir W, Mcgarry K. Disclosure and adverse effects of complementary and alternative 
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Massage - “…bringing up blood that was then 
detected in hospital has clot in lungs.” (R154) 
Homeopathy - “Reading of blood sugar went 
high.” (R156) 
Potential interactions with prescribed drugs. 
When considering patients’ HS use, potential 
interactions with prescription drugs could be 
identified in 82 patients (45.8%). The potential 
interactions between HS and prescribed medicines 
are elaborated in Table 5. Most potential 
interactions were implicated with non-steroidal anti-
inflammatory drugs (NSAIDs), anticoagulants, 
antiplatelets, antihypertensives (e.g. angiotensin-
converting enzyme inhibitors) and diuretics. Other 
significant interactions were concerned with narrow 
therapeutic index drugs, such as digoxin and 
theophylline.  
Associations of perceived CAM side-effects and 
patients’ factors. As shown in Table 6, patients’ 
perceptions of CAM side-effects were associated 
with their gender (P=0.048) and consideration for 
future use of CAM (P=0.033); the strengths of 
associations as denoted by Cramer’s V values were 
16.0% and 14.9%, respectively. Nevertheless, there 
was no relationship of perceived side-effects with 
other factors, i.e. the age group, education, ethnic 
background, specialty wards or use of CAM.  
 
DISCUSSION 
The knowledge of CAM used by in-patients in the 
UK and around the whole has been limited. This 
Table 2.  Specific types of complementary and alternative medicine (CAM) used by in-patients 
Number of patients
a 
Complementary and alternative medicine  Use within one 
month (n=91) 
Use within two years 
(n=179) 
Herbal remedies/dietary supplements (HS)   
Nutritional oil
  42 72 
Vitamins and mineral supplements  32  58 
Glucosamine   31  52 
Valerian products (Kalms)
  10 32 
Herbal teas  21  31 
Garlic 
  11 23 
Evening primrose 
  10 23 
Aloe Vera  1  12 
Echinacea 4  10 
Brewer’s yeast  3  6 
Devils claw 
  1 4 
Kelp and other seaweed  1  3 
Chinese herbs  0  2 
Linseed 1  1 
Aniseed 1  1 
Milk thistle  1  1 
Rhubarb pill  1  1 
Rose hip  1  1 
St John's wort  0  1 
Black cohosh
  0 1 
Fever few  0  1 
Ginseng 0  1 
Gingko biloba  0 1 
Acidophilus 0  1 
Liver 52  0  1 
New Zealand green mussel  0  1 
Herbal laxative  0  1 
Adios slimming pill  0  1 
Clove oil  0  1 
Herbal pack   0  1 
Cannabis 0  1 
Castor oil  0  1 
Prostrate plus  0  1 
Other forms of CAM (non-HS)     
Massage
  8 42 
Aromatherapy 10  29 
Acupuncture 3  22 
Reflexology
  3 13 
Homeopathic remedies
  4 11 
Chiropractic 2  11 
Osteopathy 1  5 
Alexander technique  0  2 
Copper band  2  2 
Bowen therapy  0  2 
Reiki 1  1 
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study reflected the views of in-patients who were 
mainly white, older British, which corresponded to 
the large number of white British in the North East 
region (92.4%).
27 The prevalence of CAM use within 
two years (74.6%) found in this study was higher 
than that of other studies in ambulatory and 
hospitalised patients
4-8,14,16, but lower than Shorofi’s 
study in Australia (90.4%).
17 These discrepancies 
were probably due to the different characteristics of 
studied population, diverse types of CAM available 
in the regions and reported duration of CAM use. 
No prevalence of CAM applications within a month 
or during admission had been previously reported in 
the UK, except this study.  
With respect to the disclosure of CAM use, there 
was little evidence of in-patients revealing their 
applications of CAM during hospital stay in the UK 
and abroad, and few studies mainly focused on the 
CAM disclosure to medical doctors and nurses.
28-29 
Goldstein  et al.
18 and Cockayne et al.
30 indicated 
that patients’ CAM use history during or prior to 
admission was rarely recorded in the medical notes. 
Similar to this study, in-patients’ disclosure rate of 
20% or lower was confirmed by other CAM 
studies.
6,8,17 A possible explanation was that 
patients were not specifically asked about CAM 
usage, as most healthcare practitioners usually 
pose the generally question - “Are you taking any 
other medicines?”. They might not regard CAM as 
either prescription or over-the-counter (OTC) 
medicines, thus limiting the disclosure of CAM use 
as ascertained by the study of Adusumilli and his 
team.
6 Moreover, the attitudes of healthcare 
professionals towards CAM also affected their 
willingness to unveil their utilisation of CAM. This 
might also be a reason for under-reporting of CAM 
adverse effects.  
Slightly more than half of the patients (57.6%) were 
aware of CAM side-effects and their perceptions 
were associated with gender and consideration for 
future use. Compared with male patients who were 
mostly not sure about CAM side-effects, females 
were likely to perceive the adverse effects, albeit 
less harmful and use more CAM. The frequent use 
of CAM as well as health services in general by 
female patients was confirmed by Murray and 
Shepherd.
31 Additionally, patients who thought 
about using CAM in the future tended to express 
their views on CAM side-effects, which were less 
than conventional drugs. Interestingly, the 
association between the previous or present use of 
CAM and perceived side-effects was not found in 
this study, possibly because most patients were not 
certain about CAM adverse effects, i.e. whether it 
could really cause a problem. This could be another 
possible explanation for under-reporting of adverse 
drug or CAM effects.
32  
Although some patients found it difficult to describe 
CAM side-effects, nearly half of patients (45.8%) 
who used CAM within two years could report 133 
adverse events. These side-effects were largely 
mild to moderate with only few serious or life-
threatening events, e.g. haemoptysis by patient with 
pulmonary embolism resulted from massage and 
syncope as a result of Alexander technique. This 
result differed from previous studies
6,8 that only 
documented theoretically potential adverse effects 
based on patients’ use of CAM. A recent study 
however published side-effects observed by 
ambulatory hypertensive patients.
16 It should be 
noted that the adverse CAM reactions (or ‘actual 
CAM side-effects) experienced by patients could not 
be classified as Type A or B according to the 
Rawlins-Thompson classification
33 due to the 
Table 3.  Reasons for disclosure and non-disclosure of complementary and alternative medicine (CAM) 
utilised by in-patients 
Reason Number  of  reports 
Disclosure of CAM use   
Asked by healthcare professionals   23 
Willing to answer  20 
Good attitudes of healthcare professionals  7 
Approved to use CAM  7 
Concerned about CAM adverse effects  7 
Brought medicines and CAM to hospital  6 
Had CAM on list of medicines  6 
Volunteered use  4 
Disclosed CAM in pre-assessment  3 
Investigated by pharmacists  1 
Non-disclosure of CAM use   
Did not consider CAM as medicines   94 
Did not use CAM currently  77 
Not asked specifically about CAM  54 
Might mention if taking  12 
Did not bring it to hospital  9 
Confused and said ‘no’  9 
Not important to report  7 
Health professionals were not interested in responses  7 
Not given CAM a thought  4 
Taking prescription or over-the-counter (OTC) medicines only  4 
Did not wish to disclose use  2 
Misunderstood the question  1 
Fear of a negative impact (stop treatment)  1 
Thought of cultural bias towards CAM  1 
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complexity of the events. With limited information, 
the CAM practices or medicines were however 
considered as ‘possible’ causes of adverse effects 
based on the simple causality assessment.  
The incidence of potential interactions between HS 
and conventional drugs is low
15,18 and remains 
unreported in hospitalised patients. An attempt was 
made in this study to assess the theoretical 
potential interactions, but there might be risk of 
exaggerating or underestimating the interactions 
due to researchers’ background or unavailable 
evidence. Whether drug-CAM interactions are 
clinically significant, it should be prudent when 
managing patients’ concomitant use of CAM and 
Table 4.  Actual complementary and alternative medicine (CAM) side-effects reported by in-patients as categorised by 
body systems 
Side-effect (number of reports)  Attributed CAM 
Gastrointestinal (42)   
Constipation  Evening primrose, cod liver oil, powder for arthritis  
Darkened stool  Multivitamin (iron) 
Diarrhoea  Multivitamin (iron), Califig herbal laxative, herbal tea   
Nausea   Homeopathy, agnus castus, supplement hormone pre-menopause   
Vomiting, sick   Garlic, aloe vera, aromatherapy, evening primrose, herbal tea, cod 
liver oil  
Increased defecation, not diarrhoea  Creatine and protein shake 
Flatulence, bloating, indigestion  cod liver oil, dandelion, seaweed (kelp) and valerian product  
Heart burn  Garlic and magnesium  
Regurgitation, rifting  Cod liver oil, garlic  
Stomach discomfort, upset, rebellious Glucosamine,  Chinese herbs, devils claw, valerian product and Iron  
Wind  Seaweed, cod liver 
Belching, burp  Cod liver, garlic  
Central nervous system (34)   
Bitter, bad taste  Chinese herbs 
Mouth felt funny  Garlic  
Bad breath   Homeopathy, Chinese herbs, garlic  
Headache, exploding head  Agnus castus, supplements for hormone 
Seizures Acupuncture 
Syncope, faint  Mixture liquid from herbalist, Alexander technique 
Nightmares Black  cohosh 
Dazed Massage 
Dizziness or light headedness  Chiropractic, evening primrose, valerian product, angus containing 
vitamin B, adios slimming pill 
Anger, aggression  Homeopathy, massage 
Tiredness homeopathy 
Increased night sweats  Black cohosh 
Pain, soreness, hurt, aches  Massage, osteopathy, chiropractic, reflexology, valerian product 
Thirst Aqua  balm 
Restless Valerian  product 
Respiratory (7)   
Haemoptysis and pulmonary embolism  Massage 
Feel ill, flu like   St John’s wort , reflexology and cod liver oil  
Affected breathing  Osteopathy 
Wheeze Glucosamine 
Endocrine system (1)   
Increased blood sugar  Homeopathy 
Skin (8)   
Tingling, dry, hash, rash  Aromatherapy, homeopathy, massage, aloe vera, valerian product, 
Chinese herbs 
Bruises Massage 
Musculoskeletal (17)   
Pain, soreness, aches, burning muscles, 
stiffness  Massage, osteopathy, chiropractic, reflexology, valerian 
Obstetrics and gynaecology, and urinary tract 
disorders (3) 
 
Thrush Vitamin  B 
Increased period  St John’s wort 
Increased urination  Massage 
Allergies (3)   
Allergy, plaster allergy  Osteopathy, herbal tea 
Swollen tongue  Glucosamine 
Other general signs and symptoms (18)   
Not feel right, made feel worse  Seaweed, dandelion 
Aggravated condition, made worse  Chiropractic 
Aggressive, vigorous procedure  Massage  
Felt beaten up  Massage  
Discomfort, uncomfortable, not feel right  Chiropractic, osteopathy, massage, seaweed  Bello N, Winit-Watjana W, Baqir W, Mcgarry K. Disclosure and adverse effects of complementary and alternative 
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conventional drugs.
13 In this study, grape fruit juice 
was not clearly specified by patients, as they might 
occasionally use it alone or as a constituent in 
herbal teas. Its interactions with conventional drugs 
are of paramount important owing to enzyme 
inhibitory effects.
34 
Limitations of the study. The main limitations 
included patients’ recall bias and interpretations of 
open-response questions. Some patients were 
unable to memorise the use of CAM within two 
years or elaborate the specific type of CAM. The 
bias therefore impacted on the documentation of 
CAM use. Since patients were allowed to express 
their views freely on all queries, some responded 
with the answers ‘yes’ together with explanations of 
‘no’, or vice versa. These ambiguous responses 
made it very challenging to perform the content 
analysis. As there were many activities on the 
wards, i.e. morning and afternoon ward rounds, 
meal times, family visiting and patient rest periods, 
an appropriate time slot for interviews was usually 
between 11 am and 12 noon during weekdays. It 
thus took very long time to finish up all interviews. 
Additionally, the findings might not be fully 
applicable to the non-white population, or ethnic 
minorities, who normally utilise CAM, for the 
majority of patients in this study were white British 
that were consistent with the population 
demographics in the North East region. 
 
CONCLUSIONS 
This study could investigate the prevalence, 
disclosure and adverse effects of CAM use in 
hospitalised patients and the associations of 
perceived side-effects with patients’ gender and 
Table 5.  Potential interactions of herbal remedies/dietary supplement (HS) and prescribed drugs 
Herbal remedy/ dietary 
supplement  Prescribed drug  Potential interaction 
Glucosamine Metformin    Increased  blood glucose in diabetic patients 
  Warfarin, tinzaparin, clopidogrel  Increased international normalised ratio (INR; a case of 
decreased INR reported) 
  Aspirin, indomethacin, ibuprofen, 
diclofenac 
May increase anti-inflammatory effects; should be taken 
with caution with antiplatelets. 
  Bendroflumethiazide, furosemide, 
spironolactone  
Slightly reduced efficacy of glucosamine.  
 
  Lisinopril, perindopril, ramipril   May antagonise antihypertensive effect (esp. 
benazepril) 
  Amlodipine, moxonidine, felodipine, 
atenolol 
May increase levels of potassium or sodium  depending 
on specific products of glucosamine 
  Doxycycline  Increased serum tetracycline level 
  Paracetamol, co-dydramol 
(paracetamol & codeine) 
May reduce efficacy of paracetamol 
 
Garlic 
 
Tinzaparin, aspirin, ibuprofen, 
naproxen, diclofenac 
Additive antiplatelet and anticoagulant effects increase 
risk of bleeding 
 
Lisinopril, perindopril, ramipril  
Diltiazem, atenolol, propanolol, 
bisoprolol 
Bendroflumethiazide, furosemide, 
spironolactone,  
Marked hypotension found in lisinopril 
May increase antihypertensive effects - lower blood 
pressure 
Diltiazem increased the inhibitory chronotropism of 
garlic on right atria. 
 Metformin,  mixtard  May improve glucose control, requiring reduction in 
antidiabetics 
Valerian products (like 
calms) 
 
Tramadol, codeine, metoclopramide, 
cyclizine, amitriptyline and 
quetiapine 
May cause excessive depression, sedation and 
cognitive impairment; possibly occur in other drugs with 
sedative properties 
 Enalapril  May increase photosensitivity, adding to risk of sunburn 
or rash 
Evening primrose 
 
 
 
Aspirin, diclofenac, rofecoxib, 
ibuprofen 
Due to production of prostaglandin E, anti-inflammatory 
effects of nonsteroidal anti-inflammatory drugs (NSAIDs) 
could be opposed.  Evening primrose has potential anti-
platelet properties.  
  Amitriptyline, venlafaxine, 
citalopram, thioridazine 
May lower seizure threshold and increase the risk for 
seizure activity.  
Echinacea   Paracetamol, pravastatin  May increase risk of hepatotocixity 
  Aspirin, ibuprofen, naproxen, 
tinzaparin 
May increase risk of bleeding because of coumarin 
derivatives in the herb 
  Prednisolone, methotrexate  May interfere with immunosuppressive effect 
 Theophylline May reduce clearance, increasing the effects  and side-
effects 
Black cohosh  
  Atenolol   May increase peripheral vasodilatation, resulting in 
hypotension  
Kelp  ibuprofen  May increase risk of bleeding 
Linseed  Ramipril  May increase risk of hypotension 
Ginkgo biloba  Ibuprofen  May increase risk of bleeding because of coumarin and 
antiplatelet activity 
Rosehip   Iron, diclofenac, warfarin  May increase absorption of iron; possible interactions 
with warfarin  
Rhubarb Prednisolone    Possible risk of hypokalaemia Bello N, Winit-Watjana W, Baqir W, Mcgarry K. Disclosure and adverse effects of complementary and alternative 
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consideration for future use. Healthcare 
professionals should encourage patients to unveil 
their CAM use and any suspected adverse effects 
by self-reporting. The uncovered data must be also 
recorded in medical notes or via the Yellow Card 
Scheme35, which is a spontaneous reporting 
system for collecting information on suspected 
adverse drug reactions (ADRs) to medicines in the 
UK. Furthermore, potential interactions between 
CAM and conventional drugs or underlying diseases 
should be assessed on a regular basis. As part of a 
pharmacovigilance system in hospital, pharmacists 
can have a role in monitoring patients’ CAM use in 
order to ensure patient safety and effective 
medicines management. It is essential that 
regulatory standards to balance the CAM safety, 
availability and accessibility to the public and 
patients are taken into account by health policy 
makers. Further studies are needed to evaluate 
specific CAM usage and related adverse events in 
specific groups of patients to ascertain the CAM 
effectiveness and safety. 
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